Article Figures & Data
- Table 1
Trial assessment flow chart
Baseline Treatment Follow-up Visit V1 V2 V3 V4 V5 V6 V7 Day-visit D1 (−4.5 h to
0 h)D1 (0 h) D2 (24 h ±2 h) D4 (72 h ±6 h) D8±l d D31±3 d D91±7 d Informed consent X Demographic data X Weight X Medical history X Inclusion/exclusion criteria X Vital signs X X X X X X Physical examination X X Brain CT/MRI X X Pregnancy tests X Haematology X X X Urinalysis X X Stool routine test X Blood chemistry X X X Coagulation test X X X Finger blood glucose Testm X ECG X X X NIHSS X X X mRS X (prestroke) X X Barthel lndex X X Randomisation X Administration X Concomitant medications X Procedure D1 (−4.5 h ±0 h) D1 (0 h) D2 (24 h ±2 h) D4 (72 h ±6 h) D8±l d D31±3 d D91±7 d Adverse events X CT, computed tomographic; D, day/days; h, hour/hours; MRI, Magnetic Resonance Imaging; mRS, modified Rankin Scale; NIHSS, National Institutes of Health Stroke Scale.
Supplementary Materials
Supplementary data
Supplementary data
Supplementary data
Supplementary data
Additional Files
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Vol 9 Issue 5
Table of Contents
